Stereoselectivity of proclidine binding to muscarinic receptor subtypes M₁, M₂ and M₄WAELBROECK, M; CAMUS, J; TASTENOY, M et al.European journal of pharmacology. 1990, Vol 189, Num 2-3, pp 135-142, issn 0014-2999, 8 p.Article

Muscarinic M₂ receptor synthesis : study of receptor turnover with propylbenzilylcholine mustardEL-BDAOUI HADDAD; ROUSELL, J; BARNES, P. J et al.European journal of pharmacology. Molecular pharmacology section. 1995, Vol 290, Num 3, pp 201-205, issn 0922-4106Article

Loss of pirenzepine regional selectivity following solubilitization and partial purification of the putative M₁ and M₂ muscarinic receptor subtypesBAUMGOLD, J; MERRIL, C; GERSHON, E. S et al.Brain research. 1987, Vol 2, Num 1, pp 7-14, issn 0006-8993Article

Binding of wild type and chimeric arrestins to the m2 muscarinic cholinergic receptorGUREVICH, V. V; RICHARDSON, R. M; KIM, C. M et al.The Journal of biological chemistry (Print). 1993, Vol 268, Num 23, pp 16879-16882, issn 0021-9258Article

3-α-Chlorimperialine : an M₂-selective muscarinic receptor antagonist that penetrates into brainBAUMGOLD, J; PRYZBYC, R. L; REBA, R. C et al.European journal of pharmacology. 1994, Vol 251, Num 2-3, pp 315-317, issn 0014-2999Article

Molecular hydropathicity index : Application to a series of allosteric modulators of the M₂ receptors : Importance of lipophilicity in molecular designVISTOLI, G; PEDRETTI, A; VILLA, A. M et al.Analusis (Imprimé). 1999, Vol 27, Num 1, pp 32-41, issn 0365-4877Article

Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptorBARBIER, P; COLELLI, A; BOLOGNESI, M. L et al.European journal of pharmacology. 1998, Vol 355, Num 2-3, pp 267-274, issn 0014-2999Article

Dysfunctional muscarinic M₂ autoreceptors in vagally induced bronchoconstriction of conscious guinea pigs after the early allergic reactionTEN BERGE, R. E. J; KRIKKE, M; TEISMAN, A. C. H et al.European journal of pharmacology. 1996, Vol 318, Num 1, pp 131-139, issn 0014-2999Article

Autoradiographic analyses of agonist binding to muscarinic receptor subtypesMESSER, W. S. JR; ELLERBROCK, B; PRICE, M et al.Biochemical pharmacology. 1989, Vol 38, Num 5, pp 837-850, issn 0006-2952Article

The role of M₂ muscarinic receptors in the posterior hypothalamus in the pressor response to intracerebroventricularly-injectedXIAO, Y.-F; BREZENOFF, H. E.Neuropharmacology. 1988, Vol 27, Num 10, pp 1061-1065, issn 0028-3908Article

Regional distribution of muscarinic receptors preferring gallamine in the rat brainPRICE, M; MESSER, W. S. JR; HOSS, W et al.Biochemical pharmacology. 1986, Vol 35, Num 23, pp 4171-4176, issn 0006-2952Article

Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflexDETINEO, Marcella L; CLARK, Kirk; BAROODY, Fuad M et al.Journal of allergy and clinical immunology. 2001, Vol 107, Num 1, pp 194-195, issn 0091-6749Article

Conformational analysis and receptor modelling of m1 and m2 selective antagonistsKERCKHOFF, H; HÖLTJE, H.-D.Pharmazie. 1994, Vol 49, Num 8, pp 566-573, issn 0031-7144Article

Expression of muscarinic M2 receptors in cultured human airway smooth muscle cellsWIDDOP, S; DAYKIN, K; HALL, I. P et al.American journal of respiratory cell and molecular biology. 1993, Vol 9, Num 5, pp 541-546, issn 1044-1549Article

Differential regulation of M₂ muscarinic receptors by guanine nucleotides in rat cerebral cortical and cardiac membranesJIAN-XIN WANG; YAMAMURA, H. I; WAN WANG et al.European journal of pharmacology. 1987, Vol 139, Num 3, pp 357-358, issn 0014-2999Article

Structural correlates for down-regulation of m1 and m2 muscarinic receptor subtypesMALATYNSKA, E; WAITE, S; WEI, H.-B et al.Brain research bulletin. 1998, Vol 47, Num 3, pp 285-290, issn 0361-9230Article

Otenzepad shows two populations of binding sites in human gastric smooth muscleBELLIDO, I; FERNANDEZ, J. L; GOMEZ, A et al.Canadian journal of physiology and pharmacology. 1995, Vol 73, Num 1, pp 124-129, issn 0008-4212Article

cis-Methyldioxolane specifically recognizes the m2 muscarinic receptorHUFF, R. A; ABOU-DONIA, M. B.Journal of neurochemistry. 1994, Vol 62, Num 1, pp 388-391, issn 0022-3042Article

Methoctramine induces nonspecific airway hyperresponsiveness in vivoHOWELL, R. E; KOVALSKY, M. P; LAEMONT, K. D et al.European journal of pharmacology. 1994, Vol 265, Num 1-2, pp 67-75, issn 0014-2999Article

Chimeric m2/m3 muscarinic receptors : role of carboxyl terminal receptor domains in selectivity of ligandl binding and coupling to phosphoinositide hydrolysisWESS, J; BONNER, T. I; BRANN, M. R et al.Molecular pharmacology. 1990, Vol 38, Num 6, pp 872-877, issn 0026-895X, 6 p.Article

Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptorJACOBY, D. B; GLEICH, G. J; FRYER, A. D et al.The Journal of clinical investigation. 1993, Vol 91, Num 4, pp 1314-1318, issn 0021-9738Article

Muscarinic M₂ receptors in rat brain labeled with [³H] AF-DX 384CASTOLDI, A. F; FITZGERALD, B; MANZO, L et al.Research communications in chemical pathology and pharmacology. 1991, Vol 74, Num 3, pp 371-374, issn 0034-5164Article

Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypesLAMBRECHT, G; FEIFEL, R; MOSER, U et al.European journal of pharmacology. 1988, Vol 155, Num 1-2, pp 167-170, issn 0014-2999Article

Delta cell secretory responses to insulin secretagogues are not mediated indirectly by insulinHAUGE-EVANS, A. C; ANDERSON, R. L; PERSAUD, S. J et al.Diabetologia (Berlin). 2012, Vol 55, Num 7, pp 1995-2004, issn 0012-186X, 10 p.Article

Investigating the interaction of McN-A-343 with the M₂ muscarinic receptor using its nitrogen mustard derivativeSUGA, Hinako; EHLERT, Frederick J.Biochemical pharmacology. 2010, Vol 79, Num 7, pp 1025-1035, issn 0006-2952, 11 p.Article